A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression

NCT04423757 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

45

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment challenges

Conditions

Depressive Disorder, Major

Interventions

DRUG: BI 1358894
DRUG: Placebo

Sponsor

Boehringer Ingelheim